Orange Health Labs posted ₹138.6 crore in operating revenue for FY26, ended March 2026, up 65% from ₹84 crore a year earlier.

Losses nearly doubled to ₹100 crore as the Bengaluru diagnostics firm expanded across Mumbai, Delhi NCR and Hyderabad.

Total expenses rose 36% to ₹240.3 crore. Employee benefits climbed 43% to ₹72.2 crore, testing materials rose 40% to ₹42.9 crore, and contract costs tied to insurance claims reached ₹35.8 crore. Marketing spend held flat at ₹34.4 crore. Overhead — rent, R&D, IT, legal and professional fees — added ₹55 crore.

Orange Health spent ₹1.73 to earn every rupee of revenue in FY26. The company says it is 20% EBITDA profitable in Bengaluru and operationally profitable across all active cities, with an exit annualized run rate of ₹180 crore.

How It Compares

Orange Health’s revenue trails larger diagnostics rivals. Thyrocare reported ₹829 crore in FY26 revenue and ₹163 crore in profit. Redcliffe Labs posted ₹419 crore and Healthians ₹263 crore, both unprofitable at that scale. On cash burn, Orange Health’s ₹100 crore loss falls between Tata 1mg’s ₹287 crore and Cashfree’s ₹118.5 crore, though the three operate at different volumes and margins.

The company added 60 collection centres over the past year, about 50 of them in Bengaluru, and has onboarded more than 2,000 clinics to its B2B diagnostics platform. It also runs a direct-to-consumer arm offering at-home sample collection.

Diagnostics services generated all operating revenue. Investment gains added ₹4.7 crore, taking total income to ₹143 crore. Loss before tax widened 11% to ₹97 crore. A ₹49 crore deferred tax expense pushed the net loss to ₹146 crore.

Orange Health raised a $30 million Series C led by Iron Pillar. Co-founder Dhruv Gupta called FY26 an inflection point for the company.

Sources

  • Entrackr: RoC filings; revenue, expenses, loss, unit economics, collection centre expansion, clinic onboarding
  • Indian Retailer: peer revenue comparisons (Thyrocare, Redcliffe Labs, Healthians)
  • Indian Pharma Post: ARR, EBITDA profitability claims, geographic expansion
  • The Print: ARR confirmation, order volume (3M+), EBITDA profitability claim, product launches

Reporting compiled and contextualised by TechScoop India. Figures reconciled across the sources above.

Originally reported by entrackr.